Frozen Shoulder Syndrome Market Driven by Aging Population and Sports Injury Incidence | GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc.

The global frozen shoulder treatment market size was valued US$ 2,601.83 Million in 2024 and is estimated to reach USD 4,171.32 Million by 2033, growing at a CAGR of 5.6% during the forecast period (2025-2033).

Frozen Shoulder Syndrome Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With an aging population, rising musculoskeletal disorders, and demand for both physiotherapeutic and surgical interventions, the report delivers strategic insights for stakeholders from 2025 to 2033.

In March 2025, a Delphi study involving U.S. and global experts established new consensus on diagnostic criteria, risk factors, and management guidelines helping standardize clinical practice and streamline care pathways. In Japan, traditional Kampo-based formulas like Nijutsuto, used alongside exercise regimens, have shown supportive outcomes in refractory cases, spotlighting integrative therapeutic strategies gaining regional traction.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/frozen-shoulder-syndrome-market?ophp

Frozen shoulder syndrome (adhesive capsulitis) is a musculoskeletal condition characterized by pain and restricted movement in the shoulder joint. The treatment market includes physical therapy, corticosteroid injections, and surgical interventions, with growth fueled by aging populations, sports injuries, and rising incidence in diabetic patients.

Frozen Shoulder Syndrome Market Competitors Overview:

GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc., Vintage Pharma, Dr. Reddy's Laboratories Ltd, Marksans Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Perrigo Company

Important Industry Updates:

Bayer adds menopause drugs to the pipeline with KaNDy acquisition. At the onset of the year, KaNDy completed a phase 2b trial of its first-in-class drug NT-814, showing activity against symptoms of menopause such as hot flashes and night sweats. A phase 3 trial is expected to have begun in 2021, and the company believes that the compound could generate peak sales of more than a billion euros globally.

Methodology and Scope

The Frozen Shoulder Syndrome Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/frozen-shoulder-syndrome-market?ophp

Frozen Shoulder Syndrome Market Segments Overview:

By Treatment (Physical therapy, Medication, Joint distension, Surgery, Others), By End-user (Hospitals, Homecare, Other)

Regional Overview for Frozen Shoulder Syndrome Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=frozen-shoulder-syndrome-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Frozen Shoulder Syndrome market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Frozen Shoulder Syndrome market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.